Thomas H Glocer - Net Worth and Insider Trading

Thomas H Glocer Net Worth

The estimated net worth of Thomas H Glocer is at least $13 Million dollars as of 2024-11-08. Thomas H Glocer is the Director of Morgan Stanley and owns about 98,110 shares of Morgan Stanley (MS) stock worth over $13 Million. Thomas H Glocer is also the Director of Merck & Co Inc and owns about 5,100 shares of Merck & Co Inc (MRK) stock worth over $515,967. Details can be seen in Thomas H Glocer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas H Glocer has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Thomas H Glocer

Thomas H Glocer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas H Glocer owns 4 companies in total, including Morgan Stanley (PEL) , Merck & Co Inc (MRK) , and Morgan Stanley (MS) among others .

Click here to see the complete history of Thomas H Glocer’s form 4 insider trades.

Insider Ownership Summary of Thomas H Glocer

Ticker	Comapny	Transaction Date	Type of Owner
PEL	Morgan Stanley	2020-06-01	director
MRK	Merck & Co Inc	2019-05-31	director
MS	Morgan Stanley	2023-05-03	director
		2019-05-31	director

Thomas H Glocer Latest Holdings Summary

Thomas H Glocer currently owns a total of 2 stocks. Among these stocks, Thomas H Glocer owns 98,110 shares of Morgan Stanley (MS) as of May 3, 2023, with a value of $13 Million and a weighting of 96.07%. Thomas H Glocer also owns 5,100 shares of Merck & Co Inc (MRK) as of February 4, 2019, with a value of $515,967 and a weighting of 3.93%.

Latest Holdings of Thomas H Glocer

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MS	Morgan Stanley	2023-05-03	98,110	128.44	12,601,248
MRK	Merck & Co Inc	2019-02-04	5,100	101.17	515,967

Holding Weightings of Thomas H Glocer

Thomas H Glocer Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas H Glocer has made a total of 1 transactions in Morgan Stanley (MS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Morgan Stanley is the sale of 4,535 shares on May 3, 2023, which brought Thomas H Glocer around $395,044.

According to the SEC Form 4 filings, Thomas H Glocer has made a total of 0 transactions in Merck & Co Inc (MRK) over the past 5 years. The most-recent trade in Merck & Co Inc is the sale of 10,000 shares on February 4, 2019, which brought Thomas H Glocer around $759,600.

Insider Trading History of Thomas H Glocer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas H Glocer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas H Glocer Ownership Network

Ownership Network List of Thomas H Glocer

No Data

Ownership Network Relation of Thomas H Glocer

Thomas H Glocer Owned Company Details

What does Morgan Stanley do?

Who are the key executives at Morgan Stanley?

Thomas H Glocer is the director of Morgan Stanley. Other key executives at Morgan Stanley include Head of Wealth Management Andrew M Saperstein , Head of Tech/Ops/Resilience Robert P Rooney , and Chief Risk Officer Keishi Hotsuki .

Morgan Stanley (PEL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Morgan Stanley (PEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Morgan Stanley (PEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Morgan Stanley (PEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Morgan Stanley Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Thomas H Glocer is the director of Merck & Co Inc. Other key executives at Merck & Co Inc include EVP & CFO Caroline Litchfield , Evp & Global Svcs & CFO Robert M Davis , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Thomas H Glocer made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 21,040 shares made by Johannes Jacobus Oosthuizen , a net sale of 8,750 shares made by Steven Mizell , and a net sale of 1,089 shares made by Joseph Romanelli .

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 364,167 shares of Merck & Co Inc (MRK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 364,167 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

What does Morgan Stanley do?

Who are the key executives at Morgan Stanley?

Thomas H Glocer is the director of Morgan Stanley. Other key executives at Morgan Stanley include Chief Human Resources Officer Mandell Crawley , Chief Financial Officer Sharon Yeshaya , and Deputy Chief Financial Officer Raja Akram .

Morgan Stanley (MS) Insider Trades Summary

Over the past 18 months, Thomas H Glocer made no insider transaction in Morgan Stanley (MS). Other recent insider transactions involving Morgan Stanley (MS) include a net sale of 750,000 shares made by James P Gorman , a net sale of 39,820 shares made by Raja Akram , and a net sale of 85,909 shares made by Andrew M Saperstein .

In summary, during the past 3 months, insiders sold 60,000 shares of Morgan Stanley (MS) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 1,210,263 shares of Morgan Stanley (MS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,210,263 shares.

Morgan Stanley (MS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Morgan Stanley Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Thomas H Glocer is the director of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRKPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRKPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merck & Co Inc (MRKPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Merck & Co Inc (MRKPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

Thomas H Glocer Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas H Glocer. You might contact Thomas H Glocer via mailing address: 2000 Galloping Hill Road, Kenilworth Nj 07033.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.